Atria is a Dividend King with an impressive track record for dividend growth. Eli Lilly has been raising its dividend at a more impressive pace than Altria in recent years. Altria has an ...

Eli Lilly is developing what could be the first oral GLP-1 agonist. Late-stage clinical trial data is coming this year. The stock has a steep valuation despite trading sideways since the summer.

Eli Lilly (NYSE:LLY) on Tuesday will file lawsuits against two companies that the drug giant is accusing of mass compounding its blockbuster GLP-1/GIP receptor agonist tirzepatide. Tirzepatide is ...

The family of murdered Cash App founder Bob Lee is suing his killer and the killer’s relatives, accusing them of attempting to destroy key evidence following the murder. Lee, 43, was repeatedly ...

April 2 (UPI) --Heart disease experts are hailing the results of a clinical trial that showed a strongly positive performance by Eli Lilly's drug lepodisiran, which inhibits the body's production ...

When Des Moines native Edgar Rosa decided to be a producer for the new film "Bob Trevino Likes It" he thought of how the story related to his own experience of finding "chosen family." The Des ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The boss of US pharmaceutical giant Eli Lilly has told the BBC there is no looking back from Donald Trump's decision to impose sweeping tariffs on imports from the rest of the world. In an ...

Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein ...

Eli Lilly has agreed a deal to acquire French antibody-drug conjugate (ADC) specialist Mablink, continuing a series of transactions that build its position in what has become one of the fastest ...

The boss of Eli Lilly, one of the biggest pharmaceutical companies in the world, has called US President Trump's tariffs a pivotal moment in US economic history, saying it will be hard to go back ...